Bausch Health Companies stock trades at EUR 5.05 after earnings beat

Published on 09/29/2026 at 16:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Adjusted EPS reached USD 1.26 versus USD 0.96 consensus for Q2 on July 29, 2026. The average analyst target was USD 8.00, while the NYSE quote stood at USD 5.73 on September 29, 2026.

BHC, CA0717341071, Illustration mit AI erstellt.

Bausch Health Companies stock (ISIN CA0717341071) was trading at EUR 5.05 at Lang & Schwarz on September 29, 2026, down 0.79 percent from the EUR 5.09 prior close. MarketBeat reported on September 23, 2026 that Zacks Research upgraded Bausch Health from Hold to Strong Buy. The rating change puts the recent earnings beat alongside a more constructive analyst view.

Zacks raises its rating

Zacks Research moved Bausch Health to Strong Buy from Hold in a report issued on September 22, 2026, according to MarketBeat. The broader analyst picture was more restrained: five analysts carried Hold ratings and one carried a Sell rating, leaving the average view at Hold with an USD 8.00 target.

Quarterly beat sets the baseline

Bausch Health reported adjusted EPS of USD 1.26 for the quarter ended June 30, 2026, compared with the USD 0.96 consensus estimate. That USD 0.30 gap amounted to a 31.25 percent beat. Revenue reached USD 2.83 billion versus USD 2.59 billion expected, a USD 0.24 billion difference, according to MarketBeat.

The company describes its portfolio across specialty pharmaceuticals, medical devices and over-the-counter products, with operations spanning eye health, gastroenterology, dermatology and international medicines, according to its investor-relations page. Its September 8, 2026 news listings included an expansion with YUN into Mexico and additional EMEA markets.

Target stays above NYSE quote

The average USD 8.00 analyst target stands 39.62 percent above the USD 5.73 BHC quote at the NYSE on September 29, 2026 at 10:37 a.m. EDT. Bausch Health had a market capitalization of USD 2.1 billion on the same date, so the target gap remains a material valuation reference rather than a small adjustment.

EUR 5.05 in afternoon trading

At Lang & Schwarz, Bausch Health was trading at EUR 5.05 on September 29, 2026 at 4:32 p.m. CEST, down 0.79 percent versus the EUR 5.09 prior close on September 28, 2026.